Integrated single source solution tracks samples with whole blood as direct input Reduces sample mix-ups and need to re-run tests New offering to be highlighted at ASHG 2022 along with additional posters SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using […]
Transformative alliance will help advance the World Health Organization’s strategy to end the global TB epidemic by 2035 SAN DIEGO — Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, and GenoScreen, an innovative genomics company, today announced a partnership to accelerate progress to end tuberculosis (TB) worldwide. The partnership will […]
Pierian®, a global leader in advanced clinical genomics technology and services, is pleased to announce an exciting partnership with P4 Diagnostix®, a leading-edge network of nationally recognized laboratories. Now physician-owned laboratories (POLs) that specialize in urology, gastroenterology, or women’s health, can add next-generation sequencing (NGS) testing for hereditary cancer to their routine diagnostic practice. Lowering the […]
New partnership brings transformative, high-resolution single-cell genomic technology to the field of preimplantation genetic testing in the pursuit of improved discovery and clinical outcomes. DURHAM, N.C. – BioSkryb Genomics, a pioneer in developing scientifically advanced single-cell analysis molecular tools, today announced a multi-year agreement with Cooper Genomics, a leader in the reproductive health market, to license BioSkryb’s proprietary […]
BOULDER, Colo. and SAN DIEGO — SomaLogic (NASDAQ: SLGC), a leader in AI data-driven proteomics technology, today announced the appointment of current board member and biotech veteran Troy Cox as Executive Chair to the company’s Board of Directors. The current Chair, Chuck Lillis, will remain on the board. Changes are effective as of today, October […]
The company uses computational design to control the function of RNA for molecular detection and therapeutics. SEATTLE — RNA design company Wayfinder Biosciences announced today that it raised a $3.5 million series seed round led by Notation Capital and Divergent Capital to continue its groundbreaking work in the use of RNA as a detection and therapeutic platform. RNA […]
Newest 3D cell culture solution from Corning enables production of ~12,000 spheroids of uniform size and geometry in a single flask Corning Incorporated (NYSE: GLW) today announced an addition to its 3D cell culture portfolio that provides a new solution to support spheroid culture, commonly used in advanced therapy development and cancer research. The Corning® Elplasia® […]
BOULDER, Colo. and SAN DIEGO — SomaLogic (NASDAQ: SLGC), a leader in AI data-driven proteomics technology, today announced the appointment of current board member and biotech veteran Troy Cox as Executive Chair to the company’s Board of Directors. The current Chair, Chuck Lillis, will remain on the board. Changes are effective as of today, October […]
RESEARCH TRIANGLE PARK, NC, US — Cell Microsystems Inc., a developer of advanced research tools for single cell workflows, is pleased to announce it has entered into a distribution agreement with OLS OMNI Life Sciences, a distributor of solutions in cell culture, cell counting, flow cytometry, imaging, and cell analysis. Cell Microsystems offers the CellRaft AIR® System, an integrated […]
Contract Research Agreement signed with Nicoya to transfer, develop and evaluate a SubB2M-based Surface Plasmon Resonance (SPR) test on the Alto™ Digital SPR instrument Nicoya has commercialised Alto, a next-generation benchtop SPR instrument for the highly sensitive detection of analytes such as proteins, antibodies, nucleic acids and sugars Nicoya’s Alto has the potential to deliver […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
